Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
Frontiers | Genomic Analysis Revealed New Oncogenic Signatures in TP53- Mutant Hepatocellular Carcinoma
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11 - Lung Cancer
Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma | PLOS ONE
P53 mutations in cancer and aggregation segments. Tumor site... | Download Scientific Diagram
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas - ScienceDirect
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
Subclonal Evolution of Cancer-Related Gene Mutations in p53 Immunopositive Patches in Human Skin - ScienceDirect
Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others | Nature Reviews Clinical Oncology
The role of TP53 gain-of-function mutation in multifocal glioblastoma | SpringerLink
Frontiers | Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
Frontiers | Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
Frontiers | Mutant p53 in Cancer Progression and Targeted Therapies
TP53 gain-of-function mutation promotes inflammation in glioblastoma | Cell Death & Differentiation
![Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/8261/1/fig-1-2x.jpg "Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]")
Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]
Mutations in exon 8 of TP53 are associated with shorter survival in patients with advanced lung cancer
The TP53 Website - Mutant TP53 an Oncogene!
Frontiers | Genomic Analysis Revealed New Oncogenic Signatures in TP53- Mutant Hepatocellular Carcinoma
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck | NEJM
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma - ScienceDirect
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene? | HTML
